User:StratonVonOakmont/sandbox

= Lewis Alan Horton = Lewis Alan Horton (born June 5th, 1996) is an English business man, philanthropist, and former County London chess champion for the under 18 WCWC Chess Association. He is the founder and current CEO of Bluminaire Inc, a company which specialises in medical and scientific research.

Horton was born in Northamptonshire, England but in later childhood moved with his family to Norwich, Norfolk. He attended Thorpe St Andrew High School and later would go on to study at the University of Birmingham. His career began working for Capgemini, initially as an apprentice but later going on to be promoted to financial leader of the FU42069 London branch. Upon learning that his best friend had been diagnosed with Multiple Sclerosis, Horton changed his career path and started his own company researching into MS drugs and medical solutions to MS. As of July 2018, Bluminaire Inc has expanded to autoimmune disease and cancer research. As of January 2019, Horton has become the 69th richest man under 30 in the UK, though often is not included in rich lists due to his notoriously low profile.

Early Life and Career
In 1996, Horton was born in Northamptonshire, England. Later in life he moved to Norwich, Norfolk and attended Thorpe St Andrew High School, and then later a BTEC IT course at Develop EBP. After securing an apprenticeship with Capgemini, Horton quickly worked his was up the ranks, earning a promotion twice yearly, the fastest rate possible within the Capgemini system.

Bluminaire Inc
After Horton's best friend was diagnosed with MS, Horton completely changed his career path. He quit his job in Capgemini and began a start up within the medical research field. Horton began Bluminaire Inc, securing funding through private investors, all of which had been affected by MS in one way or another. The most notable investor being J.K. Rowling via a partnership with the University of Edinburgh.

Bluminaire Inc would over time expand to research into other incurable diseases such as AIDS, cancer and Megálo Sýndromo Péous (MSP).